It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) experienced a ventricular tachycardia (vt) episode.The device delivered anti-tachycardia pacing (atp) which accelerated the rhythm into a faster vt.The device delivered electric shocks which induced the patient into ventricular fibrillation (vf).The third electric shock successfully converted the episode.Further information was received that this device delivered inappropriate anti-tachycardia pacing (atp) and one electric shock due to atrial fibrillation (af) with rapid ventricular response.Reprogramming options were discussed.No additional adverse patient effects were reported.At this time, this device remains in service.The complaint device was not returned to boston scientific, therefore, product analysis could not be performed.
|